128 related articles for article (PubMed ID: 9227563)
1. Stage-dependent changes in membrane currents in rats with monocrotaline-induced right ventricular hypertrophy.
Lee JK; Kodama I; Honjo H; Anno T; Kamiya K; Toyama J
Am J Physiol; 1997 Jun; 272(6 Pt 2):H2833-42. PubMed ID: 9227563
[TBL] [Abstract][Full Text] [Related]
2. Electrical remodeling of membrane ionic channels of hypertrophied ventricular myocytes from spontaneously hypertensive rats.
Li X; Jiang W
Chin Med J (Engl); 2000 Jul; 113(7):584-7. PubMed ID: 11776022
[TBL] [Abstract][Full Text] [Related]
3. Transient outward current in catecholamine-induced cardiac hypertrophy in the rat.
Mészáros J; Ryder KO; Hart G
Am J Physiol; 1996 Dec; 271(6 Pt 2):H2360-7. PubMed ID: 8997294
[TBL] [Abstract][Full Text] [Related]
4. Effects of development and thyroid hormone on K+ currents and K+ channel gene expression in rat ventricle.
Wickenden AD; Kaprielian R; Parker TG; Jones OT; Backx PH
J Physiol; 1997 Oct; 504 ( Pt 2)(Pt 2):271-86. PubMed ID: 9365903
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of Kv4.2 and Kv4.3 channel gene expression in right ventricular hypertrophy induced by monocrotaline in rat.
Zhang TT; Cui B; Dai DZ
Acta Pharmacol Sin; 2004 Feb; 25(2):226-30. PubMed ID: 14769214
[TBL] [Abstract][Full Text] [Related]
6. Arrhythmogenic substrate in hearts of rats with monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.
Benoist D; Stones R; Drinkhill M; Bernus O; White E
Am J Physiol Heart Circ Physiol; 2011 Jun; 300(6):H2230-7. PubMed ID: 21398591
[TBL] [Abstract][Full Text] [Related]
7. Normal regional distribution of membrane current density in rat left ventricle is altered in catecholamine-induced hypertrophy.
Bryant SM; Shipsey SJ; Hart G
Cardiovasc Res; 1999 May; 42(2):391-401. PubMed ID: 10533575
[TBL] [Abstract][Full Text] [Related]
8. Alterations in pharmacological action of the right ventricle of monocrotaline-induced pulmonary hypertensive rats.
Daicho T; Yagi T; Takano S; Marunouchi T; Abe Y; Ohara M; Takeo S; Tanonaka K
Biol Pharm Bull; 2009 Aug; 32(8):1378-84. PubMed ID: 19652377
[TBL] [Abstract][Full Text] [Related]
9. Effects of telmisartan on right ventricular remodeling induced by monocrotaline in rats.
Okada M; Harada T; Kikuzuki R; Yamawaki H; Hara Y
J Pharmacol Sci; 2009 Oct; 111(2):193-200. PubMed ID: 19809219
[TBL] [Abstract][Full Text] [Related]
10. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.
Porvasnik SL; Germain S; Embury J; Gannon KS; Jacques V; Murray J; Byrne BJ; Shacham S; Al-Mousily F
J Pharmacol Exp Ther; 2010 Aug; 334(2):364-72. PubMed ID: 20430844
[TBL] [Abstract][Full Text] [Related]
11. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
[TBL] [Abstract][Full Text] [Related]
12. Right ventricular hypertrophy causes impairment of left ventricular diastolic function in the rat.
Lamberts RR; Vaessen RJ; Westerhof N; Stienen GJ
Basic Res Cardiol; 2007 Jan; 102(1):19-27. PubMed ID: 16944361
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of the early outward current in ventricular cells isolated from normal and hypertrophied rat hearts.
Bénitah JP; Gomez AM; Bailly P; Da Ponte JP; Berson G; Delgado C; Lorente P
J Physiol; 1993 Sep; 469():111-38. PubMed ID: 7505822
[TBL] [Abstract][Full Text] [Related]
14. Characterization of erectile function in monocrotaline-treated pulmonary hypertensive rats.
Gur S; Kadowitz PJ; Thammasitboon S; Lasky JA; Hellstrom WJ
J Androl; 2009; 30(5):495-504. PubMed ID: 19201699
[TBL] [Abstract][Full Text] [Related]
15. Ventricular hypertrophy plus neurohumoral activation is necessary to alter the cardiac beta-adrenoceptor system in experimental heart failure.
Leineweber K; Brandt K; Wludyka B; Beilfuss A; Pönicke K; Heinroth-Hoffmann I; Brodde OE
Circ Res; 2002 Nov; 91(11):1056-62. PubMed ID: 12456492
[TBL] [Abstract][Full Text] [Related]
16. Characterization of right ventricular function after monocrotaline-induced pulmonary hypertension in the intact rat.
Hessel MH; Steendijk P; den Adel B; Schutte CI; van der Laarse A
Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2424-30. PubMed ID: 16731643
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol inhibits right ventricular hypertrophy induced by monocrotaline in rats.
Yang DL; Zhang HG; Xu YL; Gao YH; Yang XJ; Hao XQ; Li XH
Clin Exp Pharmacol Physiol; 2010 Feb; 37(2):150-5. PubMed ID: 19566840
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of infantile pulmonary arterial hypertension induced by monocrotaline.
Dias-Neto M; Luísa-Neves A; Pinho S; Gonçalves N; Mendes M; Eloy C; Lopes JM; Gonçalves D; Ferreira-Pinto M; Leite-Moreira AF; Henriques-Coelho T
Pediatr Cardiol; 2015 Jun; 36(5):1000-13. PubMed ID: 25608696
[TBL] [Abstract][Full Text] [Related]
19. An altered repolarizing potassium current in rat cardiac myocytes after subtotal nephrectomy.
Donohoe P; Hendry BM; Walgama OV; Bertaso F; Hopster DJ; Shattock MJ; James AF
J Am Soc Nephrol; 2000 Sep; 11(9):1589-1599. PubMed ID: 10966483
[TBL] [Abstract][Full Text] [Related]
20. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
Tofovic SP; Zhang X; Jackson EK; Dacic S; Petrusevska G
Vascul Pharmacol; 2006 Dec; 45(6):358-67. PubMed ID: 16872912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
